HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jiangxue Hou Selected Research

Bispecific Antibodies

10/2023Correction to: Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting.
8/2023Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jiangxue Hou Research Topics

Disease

2Multiple Myeloma
10/2023 - 08/2023
1Acute Promyelocytic Leukemia
12/2022

Drug/Important Bio-Agent (IBA)

2Bispecific AntibodiesIBA
10/2023 - 08/2023
1Chimeric Antigen ReceptorsIBA
08/2023
1Tretinoin (Retinoic Acid)FDA LinkGeneric
12/2022
1Arsenic Trioxide (Trisenox)FDA Link
12/2022

Therapy/Procedure

1Therapeutics
08/2023